Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects | PLOS ONE
![Clinical predictive factors in diabetic kidney disease progression - Radcliffe - 2017 - Journal of Diabetes Investigation - Wiley Online Library Clinical predictive factors in diabetic kidney disease progression - Radcliffe - 2017 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c2f25108-c00e-44fc-9bd5-22f8e3f61961/jdi12533-toc-0001-m.jpg?trick=1682313933277)
Clinical predictive factors in diabetic kidney disease progression - Radcliffe - 2017 - Journal of Diabetes Investigation - Wiley Online Library
![Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13–p12 in Japanese | Journal of Human Genetics Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13–p12 in Japanese | Journal of Human Genetics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10038-004-0199-3/MediaObjects/s10038-004-0199-3flb1a.gif)
Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13–p12 in Japanese | Journal of Human Genetics
![Figure 2 | Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes Figure 2 | Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes](https://static.hindawi.com/articles/scientifica/volume-2012/283821/figures/283821.fig.002.jpg)
Figure 2 | Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes
![Table 1 from Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. | Semantic Scholar Table 1 from Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4aa9fc3de53f9c8c935f83a01f23575c71d90821/2-Table1-1.png)
Table 1 from Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. | Semantic Scholar
![Frontiers | Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach Frontiers | Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach](https://www.frontiersin.org/files/Articles/641336/fendo-12-641336-HTML/image_m/fendo-12-641336-g001.jpg)
Frontiers | Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach
![JCM | Free Full-Text | The Distribution of Autoantibodies by Age Group in Children with Type 1 Diabetes versus Type 2 Diabetes in Southern Vietnam JCM | Free Full-Text | The Distribution of Autoantibodies by Age Group in Children with Type 1 Diabetes versus Type 2 Diabetes in Southern Vietnam](https://www.mdpi.com/jcm/jcm-12-01420/article_deploy/html/images/jcm-12-01420-g001.png)
JCM | Free Full-Text | The Distribution of Autoantibodies by Age Group in Children with Type 1 Diabetes versus Type 2 Diabetes in Southern Vietnam
![EXPRESSION OF APOPTOSIS MARKERS IN TYPE 2 DIABETES: Skin Microvasculature of Patients with Diabetes Mellitus Type 2: Tengku din, Tengku Ahmad Damitri Al-Astani: 9783838307053: Amazon.com: Books EXPRESSION OF APOPTOSIS MARKERS IN TYPE 2 DIABETES: Skin Microvasculature of Patients with Diabetes Mellitus Type 2: Tengku din, Tengku Ahmad Damitri Al-Astani: 9783838307053: Amazon.com: Books](https://m.media-amazon.com/images/I/61Mk3KiR4HS._AC_UF1000,1000_QL80_.jpg)
EXPRESSION OF APOPTOSIS MARKERS IN TYPE 2 DIABETES: Skin Microvasculature of Patients with Diabetes Mellitus Type 2: Tengku din, Tengku Ahmad Damitri Al-Astani: 9783838307053: Amazon.com: Books
![Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population | SpringerLink Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11892-018-1110-5/MediaObjects/11892_2018_1110_Fig2_HTML.png)
Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population | SpringerLink
![Abstract 12577: Markers of Residual Risk in Type 2 Diabetes and Stable Ischemic Heart Disease: Insights From the BARI 2D Trial | Circulation Abstract 12577: Markers of Residual Risk in Type 2 Diabetes and Stable Ischemic Heart Disease: Insights From the BARI 2D Trial | Circulation](https://www.ahajournals.org/cms/asset/cd9cccd9-6fad-4dcc-b3fd-02fdd4347de8/g12577.jpg)
Abstract 12577: Markers of Residual Risk in Type 2 Diabetes and Stable Ischemic Heart Disease: Insights From the BARI 2D Trial | Circulation
![Multiple elements related to metabolic markers in the context of gestational diabetes mellitus in meconium - ScienceDirect Multiple elements related to metabolic markers in the context of gestational diabetes mellitus in meconium - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0160412018315897-ga1.jpg)
Multiple elements related to metabolic markers in the context of gestational diabetes mellitus in meconium - ScienceDirect
![Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction | Biomarkers in Medicine Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction | Biomarkers in Medicine](https://www.futuremedicine.com/cms/10.2217/bmm.14.100/asset/images/medium/figure1.gif)
Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction | Biomarkers in Medicine
![Cureus | An Investigation on the Efficacy of Glucagon-Like Peptide 1 Receptor Agonists Drugs in Reducing Urine Albumin-to-Creatinine Ratio in Patients With Type 2 Diabetes: A Potential Treatment for Diabetic Nephropathy Cureus | An Investigation on the Efficacy of Glucagon-Like Peptide 1 Receptor Agonists Drugs in Reducing Urine Albumin-to-Creatinine Ratio in Patients With Type 2 Diabetes: A Potential Treatment for Diabetic Nephropathy](https://assets.cureus.com/uploads/figure/file/568135/lightbox_39058450b4d511edbe199f660708ae3c-Screen-Shot-2023-02-25-at-1.25.21-AM.png)
Cureus | An Investigation on the Efficacy of Glucagon-Like Peptide 1 Receptor Agonists Drugs in Reducing Urine Albumin-to-Creatinine Ratio in Patients With Type 2 Diabetes: A Potential Treatment for Diabetic Nephropathy
![Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population - AJPM Focus Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population - AJPM Focus](https://www.ajpmfocus.org/cms/attachment/d5f044df-321b-4817-9f0b-3c366cd535c3/ga1_lrg.jpg)